Begis SRL
Begis reported total assets of 43,714 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Begis shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +91 % Total assets -14 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Begis's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 31 Oct 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 01 Sep 2023
Begis's financial analysis
- Solvency50.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Begis
Begis's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0790.396.877
- VAT number
- BE0790396877
- Peppol
- Registered · 0208:0790396877 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Sep 2022
- Registered office
- 9860 Oosterzele
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Begis (SRL) has been based in Oosterzele since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 11,876 € and equity of 22,222 €; its revenue is not published. Its solvency stands at 50.8%, above the median of its sector (44.2%).
Companies similar to Begis
Companies in the same business, of comparable size and area, outside its group.
- PharmaSi Retail sale of pharmaceutical products Maasmechelen · balance sheet 58,595 €
- Benisa BV Retail sale of pharmaceutical products Dilsen-Stokkem · balance sheet 60,407 €
- Pharmacie Thauvin Retail sale of pharmaceutical products Ciney · balance sheet 156,263 €
- Mancha Retail sale of pharmaceutical products Edegem · balance sheet 264,945 €
- Apotheek Schoofs Kristie Retail sale of pharmaceutical products Oudsbergen · balance sheet 412,440 €
- Talpa Farma Retail sale of pharmaceutical products Anderlecht · balance sheet 547,932 €
- Apo Kuipers Retail sale of pharmaceutical products Lubbeek · balance sheet 146,357 €
- Satilmis Retail sale of pharmaceutical products Saint-Gilles · balance sheet 304,962 €
Frequently asked questions about Begis
What is the revenue of Begis?
Begis files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Begis?
In Belgium, the VAT number is the company number prefixed with BE: BE0790396877 for Begis, if the company is VAT-registered. Its company number (CBE) is 0790.396.877.
Where is the registered office of Begis?
According to the CBE register, the registered office of Begis is in 9860 Oosterzele.
What is the equity of Begis?
At the close of the 2025 financial year, the equity of Begis amounts to 22,222 €, a solvency of 50.8% of total assets.
Who manages Begis?
The register lists 1 active mandates at Begis. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Begis
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →